Your browser doesn't support javascript.
loading
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gottlieb, Robert L; Nirula, Ajay; Chen, Peter; Boscia, Joseph; Heller, Barry; Morris, Jason; Huhn, Gregory; Cardona, Jose; Mocherla, Bharat; Stosor, Valentina; Shawa, Imad; Kumar, Princy; Adams, Andrew C; Van Naarden, Jacob; Custer, Kenneth L; Durante, Michael; Oakley, Gerard; Schade, Andrew E; Holzer, Timothy R; Ebert, Philip J; Higgs, Richard E; Kallewaard, Nicole L; Sabo, Janelle; Patel, Dipak R; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M.
Afiliação
  • Gottlieb RL; Baylor University Medical Center and Baylor Scott and White Research Institute, Dallas, Texas.
  • Nirula A; Eli Lilly and Company, Indianapolis, Indiana.
  • Chen P; Department of Medicine, Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Boscia J; Vitalink Research, Union, South Carolina.
  • Heller B; Long Beach Clinical Trials, Long Beach, California.
  • Morris J; Imperial Health, Lake Charles, Louisiana.
  • Huhn G; Cook County Health, Chicago, Illinois.
  • Cardona J; Indago Research, Hialeah, Florida.
  • Mocherla B; Las Vegas Medical Research Center, Las Vegas, Nevada.
  • Stosor V; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Shawa I; Franciscan Health, Greenwood, Indiana.
  • Kumar P; Georgetown University, Washington, DC.
  • Adams AC; Eli Lilly and Company, Indianapolis, Indiana.
  • Van Naarden J; Eli Lilly and Company, Indianapolis, Indiana.
  • Custer KL; Eli Lilly and Company, Indianapolis, Indiana.
  • Durante M; Eli Lilly and Company, Indianapolis, Indiana.
  • Oakley G; Eli Lilly and Company, Indianapolis, Indiana.
  • Schade AE; Eli Lilly and Company, Indianapolis, Indiana.
  • Holzer TR; Eli Lilly and Company, Indianapolis, Indiana.
  • Ebert PJ; Eli Lilly and Company, Indianapolis, Indiana.
  • Higgs RE; Eli Lilly and Company, Indianapolis, Indiana.
  • Kallewaard NL; Eli Lilly and Company, Indianapolis, Indiana.
  • Sabo J; Eli Lilly and Company, Indianapolis, Indiana.
  • Patel DR; Eli Lilly and Company, Indianapolis, Indiana.
  • Klekotka P; Eli Lilly and Company, Indianapolis, Indiana.
  • Shen L; Eli Lilly and Company, Indianapolis, Indiana.
  • Skovronsky DM; Eli Lilly and Company, Indianapolis, Indiana.
JAMA ; 325(7): 632-644, 2021 02 16.
Article em En | MEDLINE | ID: mdl-33475701
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carga Viral / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Carga Viral / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article